FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical composition in the form of a gel or an emulsion gel for topical application containing: (a) 2 % diclofenac sodium salt, (b) at least 55 % water, (c) from 10 to 15 % of isopropyl alcohol, (d) from 10 to 15 % of propylene glycol, (e) from 2 to 3 % of at least one gelling agent selected from a group consisting of carbomers, (f) from 0 to 10 % of liquid lipid, which forms oil phase, (g) from 0 to 5 % of at least one nonionic surfactant, and (h) a basic agent for bringing the whole of the composition pH to 6–9, all percentages being weight, where (c) and (d) together form 20 to 25 % of the composition, and the viscosity of the composition is in range of 5,000 to 10,000 cP.
EFFECT: invention provides high degree of penetration through skin, absence of irritant action, high stability, complete solubility of active ingredient and effective pain relief.
10 cl, 5 ex, 2 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
TOPICAL COMPOSITION | 2008 |
|
RU2497516C2 |
ARTHRONOSOS CURE | 2007 |
|
RU2353349C2 |
DICLOFENAC GEL | 2007 |
|
RU2463038C2 |
TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY AND ANALGESIC EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2309738C1 |
EMULSION COMPOSITION FOR TOPICAL USE CONTAINING NON-STEROID ANTI-INFLAMMATORY AGENT | 2018 |
|
RU2804418C2 |
SYSTEM FOR DOSED DISTRIBUTION | 2013 |
|
RU2637420C2 |
COMBINATION OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND NON-STEROID ANTI-INFLAMMATORY DRUG FOR TREATING OR PREVENTING INFLAMMATORY SKIN INJURY | 2010 |
|
RU2532388C2 |
GEL COMPOSITION FOR TREATMENT OF STOMATOLOGICAL DISEASE AND METHOD FOR ITS PREPARING | 2004 |
|
RU2288699C2 |
APPLYING AT LEAST ONE BETA-ADRENERGIC AGONIST AS SUBSTANCE B AGONIST | 1996 |
|
RU2169552C2 |
Authors
Dates
2019-10-14—Published
2015-09-09—Filed